Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Austria Health Focus.
OSCE Supports Medical Training for Border Service Personnel in Kyrgyzstan
Organization for Security and Co-operation in Europe
·
February 19, 2025
Bishkek, 31 January 2025 – The OSCE Programme Office in Bishkek has implemented a specialized Train-the-Trainer (ToT) programme aimed at strengthening the medical response capabilities of the Border Service of the State Committee for National...
X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia
GlobeNewswire, Inc.
·
February 6, 2025
Full enrollment in ongoing global, pivotal Phase 3 clinical trial in chronic neutropenia on track for mid-2025 Right-sizing commercial efforts to optimize XOLREMDI promotion and support U.S. WHIM syndrome community Restructuring impact expected to...
Austrianova expands its operations to include sterility and endotoxin testing
EIN Presswire
·
October 24, 2024
With this expansion of services, Austrianova is further solidifying its position in GMP cell encapsulation and related services. SINGAPORE, SINGAPORE, October 25, 2024 /EINPresswire.com/ -- Austrianova, the cell encapsulation company, also...
Disposable Medical Pulp Container Market Size to Reach USD 3.27 Billion by 2032, Driven by Sustainability Trends
EIN Presswire
·
February 3, 2025
The global market is set to grow at a CAGR of 10.48% as healthcare facilities shift towards eco-friendly and biodegradable packaging solutions. AUSTIN, TX, UNITED STATES, February 3, 2025 /EINPresswire.com/ -- According to Research by SNS...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire, Inc.
·
February 3, 2025
BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued...
Medical Sensors Market to Surpass Market Valuation of USD 4.14 Billion by 2031 | SkyQuest Technology
GlobeNewswire, Inc.
·
October 18, 2024
Westford, USA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Medical Sensors Market will reach a value of USD 4.14 Billion by 2031, with a CAGR of 8.1% during the forecast period (2024-2031). Medical sensors market is...
eHealth Exchange Announces New Board Members and Leadership Appointments To Advance Payer and Public Health Strategies
GlobeNewswire, Inc.
·
January 30, 2025
VIENNA, Va., Jan. 30, 2025 (GLOBE NEWSWIRE) -- eHealth Exchange, one of the nation's largest health information networks, announces new board of directors. Four esteemed leaders will strengthen the organization’s alignment with its payer and...
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease
GlobeNewswire, Inc.
·
January 23, 2025
- Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential once-daily oral therapy for Alzheimer’s disease (AD) - - Robust and dose-dependent reductions of sTREM2 were achieved...
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
GlobeNewswire, Inc.
·
January 30, 2025
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HIV) Under the collaboration agreement, HOOKIPA...
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
GlobeNewswire, Inc.
·
January 24, 2025
Submission supported by positive results from global, Phase 3 4WHIM clinical trial; U.S. regulatory approval in WHIM syndrome granted in 2024 Decision on MAA expected in 1H 2026 BOSTON, Jan. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq:...
Employee well-being and mental health take center stage for HR leaders despite budget constraints
EIN Presswire
·
January 28, 2025
Over two-thirds of senior HR leaders aim to prioritize mental health and stress management over the next three to five years CLAYMONT, DE, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- aconso, an innovator in HR document management...
Pharmaceutical CRM Software Market to Reach $6900 Million, Globally, by 2032 at 5.2% CAGR | VMR
EIN Presswire
·
September 23, 2024
Pharmaceutical CRM Software Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2032 224 W 35TH ST STE 500, NY, UNITED STATES, September 23, 2024 /EINPresswire.com/ -- The Global Pharmaceutical CRM Software Market was...
Medical Grade Hyaluronic Acid Market to Reach $3.26 Billion, Globally, by 2034 at 7.6% CAGR | VMR
EIN Presswire
·
September 25, 2024
Medical Grade Hyaluronic Acid Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2034 224 W 35TH ST STE 500, NY, UNITED STATES, September 25, 2024 /EINPresswire.com/ -- The global Medical Grade Hyaluronic Acid Market is...
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
GlobeNewswire, Inc.
·
August 31, 2025
DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted in vitro data assessing the effects of EPA on lipoprotein(a) [Lp(a)] oxidation and on cellular stress and inflammatory...
Crohn's Disease Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA Approvals by DelveInsight
EIN Presswire
·
January 13, 2025
Crohn's Disease companies working in the market are Takeda Pharmaceutical, Janssen Pharmaceuticals, UCB, Biogen, AbbVie, AstraZeneca, Tillotts Pharma, and more. LAS VEGAS, NV, UNITED STATES, January 13, 2025 /EINPresswire.com/ -- DelveInsight’s...
From Concentration Camp to an Institute – Life's Journey of the Oncologist Majda Mačkovšek Peršič
Government of Slovenia
·
August 31, 2025
SLOVENIA, August 31 - In June 1967, a Slovenian oncologist and Director of the Institute of Oncology Ljubljana, Dr. Božena Ravnihar, wrote a letter on behalf of the institute's clinical committee to the Republic Secretariat for Health Care and...
X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand
GlobeNewswire, Inc.
·
January 13, 2025
X4 to receive a €28.5 million upfront payment and up to €226 million in potential regulatory and commercial milestone payments in addition to tiered, double-digit royalties up to the mid-twenties Upfront non-dilutive funds strengthen X4’s balance...
Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire, Inc.
·
January 12, 2025
- Ascendis positioned to drive rapid revenue growth COPENHAGEN, Denmark, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2025 key corporate milestones....
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
GlobeNewswire, Inc.
·
January 7, 2025
NEW YORK and VIENNA, Austria, Jan. 07, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for the treatment of cancer and...
Artisan Bakery Market Poised to Grow at a CAGR of 3.5%, Fueled by Rising Health and Wellness Awareness
EIN Presswire
·
January 15, 2025
Artisan Bakery Market Research Report By Product Type, Ingredients, Distribution Channel, Consumer Type, Regional NEW YORK, NY, UNITED STATES, January 15, 2025 /EINPresswire.com/ -- The Artisan Bakery Market was valued at approximately USD 36.84...